PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
NCT01642472
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Uterine Fibroids
Interventions
DRUG:
Ulipristal Acetate - open label
Sponsor
PregLem SA